Shares of Ionis Pharmaceuticals (NASDAQ:IONS) climbed 7% today after the company announced that regulatory agencies in the ...

Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose ...

CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, ...

Notable insider trades include Smyth Antonio P, Executive Vice President at American Electric Power Company Inc (AEP), who sold 4898 shares on Jun 05 ’24, at $90 each, totaling $0.44 million. On May ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

Spinraza remains a big product for Biogen but has seen its sales go into reverse as competition in SMA treatment has emerged ...

Biogen Inc. (BIIB) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New ...

Biogen’s applications for the higher dose regimen of spinal muscular atrophy (SMA) drug Spinraza are now under review in the US and Europe.

Aflac Inc (AFL) stock saw a decline, ending the day at $104.3 which represents a decrease of $-2.09 or -1.96% from the prior close of $106.39. The stock opened at $106.33 and touched a low of $104.12 ...

Critical SonicWall zero-day (CVE-2025-23006) in SMA 1000 appliances fixed. Rated 9.8 CVSS; patch now to prevent active ...

SonicWall is warning customers of a critical vulnerability that was potentially already exploited as a zero-day.

Biogen (BIIB) announced that the U.S. Food and Drug Administration, FDA, has accepted the company’s supplemental New Drug Application, sNDA, ...